Affiliation:
1. Centre de Biochimie et de Génétique Cellulaires du Centre National de la Recherche Scientifique, Toulouse, France.
Abstract
Isonicotinic acid hydrazide (isoniazid; INH) inhibition of mycolic acid synthesis was studied by using cell extracts from both INH-sensitive and -resistant strains of Mycobacterium aurum. The cell extract of the INH-sensitive strain was inhibited by INH, while the preparation from the INH-resistant strain was not. This showed that the INH resistance of mycolic acid synthesis was not due to a difference in drug uptake or the level of peroxidase activity (similar in both extracts). As INH did not induce accumulation of any labeled intermediates, it is postulated that the drug acts either on production of labeled chain elongation precursors of mycolic acids or an early step of this elongation. The level of inhibition was not changed by addition of NAD or nicotinamide; thus, INH does not act on mycolic acid synthesis as an NAD antimetabolite. Benzoic or acetic acid hydrazides and known or postulated metabolites of INH (i.e., the corresponding acid, aldehyde, or alcohol) were not inhibitors of cell-free mycolic acid synthesis; the complete structure of INH was required, as already known for inhibition of mycobacterial culture growth. Extracts prepared from INH-treated cells showed reduced mycolic acid synthesis, and the inhibition level was not modified by either extensive dialysis or pyridoxal phosphate. This latter molecule efficiently antagonized INH action by reacting rapidly with INH, as shown by differential spectroscopy. Moreover, pyridoxal phosphate did not release inhibition of INH-treated extracts. It is proposed that INH may covalently react with an essential component of the mycolic acid synthesis system.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference21 articles.
1. Capacity of tubercle bacilli for isoniazid accumulation;Beggs W. H.;Am. Rev. Respir. Dis.,1969
2. Effect of pyridoxal on uptake of 4C-activity from labelled isoniazid by Mycobacterium tuberculosis;Boone I. U.;Am. Rev. Tuberc.,1957
3. Isoniazid inhibition of the synthesis of monounsaturated long-chain fatty acids in Mycobacterium tuberculosis H37Ra;Davidson L. A.;Antimicrob. Agents Chemother.,1979
4. The purification and properties of peroxydase in Mycobacterium tuberculosis H37 Rv and its possible role in the mechanism of action of isonicotinic acid hydrazide;Gayathri Devi B.;Biochem. J.,1975
5. Iwainsky H. 1988. INH-mode of action p. 476-508. In K. Bartmann (ed.) Handbook of experimental pharmacology vol. 84: antituberculosis drugs. Springer Verlag KG Berlin.
Cited by
115 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献